Disi Medical Completes Nearly 100 Million Yuan Series A Financing to Accelerate Commercialization of Microsurgical Robots

Hangzhou Disi Medical Biotechnology Co., Ltd. recently completed a Series A financing round of nearly 100 million yuan, led by Panlin Capital, with Shangcheng Capital, Jinhe Capital, and Hangzhou Science and Technology Innovation Group (Disruptive Technology Achievement Transformation Fund) participating as co-investors. Linear Capital was the lead investor in the Pre-A round and increased its investment in subsequent rounds.